Navigation Links
Genstar Names Michael Hurt to Its Strategic Advisory Board
Date:9/5/2007

CEO of Former Portfolio Company is a Proven Leader at Driving Growth

SAN FRANCISCO, Sept. 5 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of life sciences and healthcare services, industrial technology, business services and software, today announced the appointment of Michael L. Hurt to the firm's Strategic Advisory Board (SAB). The addition of Mr. Hurt, CEO of Altra Industrial Motion (Nasdaq: AIMC), a former Genstar portfolio company, increases to 18 the number of influential senior executives who are current or former leaders of major corporations and have joined the firm in this advisory capacity.

"I have known Mike for more than 15 years since my first LBO of the company he ran and he is a multi-talented executive who repeatedly has driven growth at the businesses he has overseen," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "The Genstar team has become familiar with Mike's ability to successfully lead organizations, most recently as head of our portfolio company Altra Holdings where he achieved spectacular growth and tripled operating profit in less than three years. We are very pleased that he will now provide the skills he has obtained over nearly 40 years of working with industrial technology businesses to our management teams as we grow our investments."

Mr. Hurt is currently CEO of Altra Industrial Motion, which designs, produces, and distributes a wide range of mechanical power transmission products that serve a variety of applications. Prior to leading Altra, he worked with Genstar as an advisor in the Industrial Technology area after retiring as the President and CEO of TB Wood's Corporation in November 2003. In addition to Altra, Mr. Hurt spent thirteen years at TB Wood's and 23 years with the Torrington Company, a division of Ingersoll Rand.

A graduate of Clemson University with a BSME degree in mechanical engineering, Mr. Hurt holds an MBA degree from Clemson-Furman University. He is a registered professional engineer.

The Genstar SAB includes executives from such leading companies as Pharmacia & Upjohn, Inc., CNA Insurance Companies, ITT Corporation, Deere & Co., Axia Health Management, MedImmune, Inc., Wild Oats Markets, WellPoint, Inc., NEN Life Science Products, and ICOS Corporation.

About Genstar Capital, LLC

Based in San Francisco, Genstar Capital (http://www.gencap.com) is a private equity investment firm that makes leveraged investments in quality middle- market companies. Genstar Capital works in partnership with management to transform its portfolio companies into industry-leading businesses. With more than $3 billion of committed capital under management and significant experience investing in businesses, Genstar focuses on selected segments of life science and healthcare services, industrial technology, business services and software services.


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research and ... has announced the addition ... - Material, Application - Forecast to 2025" report to ... The report provides a detailed analysis on current ... Market forecasts till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is ... fully 21 CFR Part 11-compliant email client designed to provide product vigilance departments ...
Breaking Biology Technology:
(Date:1/19/2017)... Jan. 19, 2017 Sensory Inc ... and security for consumer electronics, and i ... systems and cybersecurity solutions, today announced a global ... financial institutions worldwide to bolster security of data ... secure user authentication platforms they offer, innerCore now ...
(Date:1/18/2017)... 2017 MedNet Solutions , an ... entire spectrum of clinical research, is proud to ... for the organization in terms of corporate growth, ... products and services. The company,s exceptional achievements can ... iMedNet ™ – ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... (ctDNA) technologies, today announced that it has signed agreements ... and the Middle East ... milestone marks the first wave of international distribution agreements ... and blood samples. The initial partners will ...
Breaking Biology News(10 mins):